683 CAPITAL MANAGEMENT, LLC – Eiger BioPharmaceuticals, Inc. Transaction History
683 CAPITAL MANAGEMENT, LLC portfolio value:
$32.60M
portfolio value
683 CAPITAL MANAGEMENT, LLC quarter portfolio value change:
+19.52%
quarter
Eiger BioPharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +12.02% | 464.75K shares | 8.25M | $7.53 | 4.32M |
| Q2 2022 | share | Increase | +14.52% | 490K shares | -3.66M | $6.3 | 3.86M |
| Q1 2022 | share | Increase | +2.27% | 75K shares | 10.88M | $8.3 | 3.37M |
| Q4 2021 | share | Increase | +3.94% | 125K shares | -4.08M | $5.21 | 3.3M |
| Q3 2021 | share | Increase | +7.63% | 225K shares | -3.92M | $6.68 | 3.17M |
| Q2 2021 | share | Increase | +9.93% | 266.4K shares | 1.38M | $8.52 | 2.95M |
| Q1 2021 | share | 0.00% | 0 shares | -9.23M | $8.85 | 2.68M | |
| Q4 2020 | share | Increase | +2.31% | 60.68K shares | 11.63M | $12.29 | 2.68M |
| Q3 2020 | share | Increase | +21.61% | 466.07K shares | 644K | $8.14 | 2.62M |
| Q2 2020 | share | Increase | +5.73% | 116.83K shares | 6.83M | $9.6 | 2.15M |
| Q1 2020 | share | Increase | +10.27% | 190K shares | -13.69M | $6.8 | 2.04M |
| Q4 2019 | share | Decrease | -0.57% | -10.52K shares | 8.49M | $14.9 | 1.85M |
| Q3 2019 | share | Increase | +1.36% | 25K shares | -386K | $10.25 | 1.86M |
| Q2 2019 | share | Increase | +13.97% | 225K shares | -3.05M | $10.6 | 1.83M |
| Q1 2019 | share | 0.00% | 0 shares | 6.15M | $13.98 | 1.61M | |
| Q4 2018 | share | Increase | +155.14% | 979.29K shares | 8.78M | $10.16 | 1.61M |
| Q3 2018 | share | Increase | +113.77% | 335.94K shares | 3.97M | $12 | 631.23K |
| Q2 2018 | share | Increase | +51.21% | 100K shares | 1.67M | $12.2 | 295.28K |
| Q1 2018 | share | Increase | 0.00% | 195.28K shares | 1.92M | $9.85 | 195.28K |